LSD is pharmacologically classified as a hallucinogen, specifically a serotonergic psychedelic, meaning its defining effects center on dramatically altered perception, cognition, and sense of self. But the drug also raises heart rate, blood pressure, and body temperature in ways that look a lot like a stimulant, and users frequently describe feeling energized and awake for hours. It does not fit the depressant category by any meaningful measure. The honest answer is that LSD is a hallucinogen first, with a genuine stimulant streak that makes the “pick one box” question more interesting than it seems.
Why It Lands in the Hallucinogen Category
The reason LSD is grouped with hallucinogens rather than stimulants or depressants comes down to which receptor does the heavy lifting. LSD’s signature psychological effects, including visual distortions, synesthesia, altered time perception, and ego dissolution, arise primarily from its action at serotonin 5-HT2A receptors in the brain. This is the same receptor targeted by psilocybin, mescaline, and DMT, the drugs collectively referred to as “classical” or “serotonergic” hallucinogens.1PubMed Central. Pharmacologic Similarities and Differences Among Hallucinogens Researchers have confirmed that LSD activates specific signaling pathways at the 5-HT2A receptor, including Gq protein dissociation and β-arrestin2 recruitment, both of which are tied to psychedelic experience.2Nature Communications. Identification of 5-HT2A receptor signaling pathways associated with psychedelic potential
What sets LSD apart from a pure stimulant like amphetamine is the nature of its psychological output. Stimulants mainly ramp up alertness, motivation, and goal-directed behavior through dopamine and norepinephrine release. LSD does something qualitatively different: it reshapes the texture of conscious experience. A head-to-head comparison in healthy volunteers found that LSD produced significantly greater “any drug effect,” “ego dissolution,” and “bad drug effect” ratings than d-amphetamine.3PubMed Central. Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects Amphetamine users feel sharper and more driven. LSD users feel like the boundaries of their self are dissolving. Those are fundamentally different pharmacological signatures, and they are why the hallucinogen label sticks.
The Stimulant Side of the Experience
That said, LSD genuinely activates the sympathetic nervous system in ways that overlap with stimulant drugs. In a controlled study of healthy subjects given a moderate dose, LSD significantly increased blood pressure, heart rate, body temperature, pupil size, and plasma levels of cortisol and epinephrine.4PubMed. Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects These are the same physiological markers you’d see after a dose of amphetamine or cocaine. A review of LSD’s cardiovascular effects confirmed that acute ingestion causes tachycardia and hypertension, consistent with other psychedelics.5PubMed Central. Lysergic Acid Diethylamide (LSD) and the Heart: Exploring the Potential Impacts of LSD on Cardiovascular Function
LSD also powerfully suppresses sleep. Research in animal models showed that LSD increases wakefulness and active arousal while decreasing both spindle sleep and REM sleep, with the wakefulness effect persisting well beyond the initial peak.6PubMed. LSD and tryptamine effects on sleep/wakefulness and electrocorticogram patterns in intact cats Anyone who has taken LSD can confirm this: falling asleep during a trip is essentially impossible, and residual alertness tends to linger for hours after the perceptual effects fade. This wakefulness-promoting quality is one of the most stimulant-like features of the drug.
Part of the explanation involves dopamine. LSD is not just a serotonin drug. It binds with high affinity to the functional high-affinity state of the dopamine D2 receptor, with one study measuring a dissociation constant of about 2 nanomolar, a remarkably potent interaction.7Molecular Psychiatry. Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics This dopamine activity likely contributes to the energized, fast-paced quality of an LSD experience and helps explain why, among the classical psychedelics, LSD tends to feel the most “speedy.”8PubMed Central. Default Mode Network Modulation by Psychedelics: A Systematic Review
Why LSD Is Not a Depressant
Depressants, sometimes called “downers,” are drugs that slow down central nervous system activity. Alcohol, benzodiazepines, and barbiturates fall into this category. They work by enhancing inhibitory signaling, typically through GABA receptors, producing sedation, muscle relaxation, impaired coordination, and at high doses, respiratory depression. LSD does essentially none of this. It does not enhance GABAergic transmission, it does not cause sedation or drowsiness at any normal dose, and it does not impair consciousness in the way depressants do. If anything, it does the opposite: brain imaging and electrophysiology studies consistently show that LSD increases cortical excitability and information throughput, rather than suppressing it.
One area where confusion sometimes arises is the concept of “ego dissolution,” the feeling of losing your sense of self that can accompany a strong LSD experience. That sounds like it could be depressive or sedating, but it is neurologically the opposite of CNS depression. It reflects a massive reorganization of brain network activity, not a slowing down of it. The distinction matters because mislabeling LSD as a depressant could lead someone to dangerously combine it with actual depressants, expecting the effects to cancel out, when in reality the combination introduces its own unpredictable risks.
What LSD Actually Does to Brain Activity
The brain under LSD is not quieter or slower. It is differently organized, and in many measurable ways, more active. EEG studies show that LSD produces broadband cortical desynchronization, meaning the rhythmic electrical patterns that normally coordinate brain regions become scrambled across a wide range of frequencies. Even low doses produce this desynchronization over the default mode network, the brain system most associated with your sense of self and internal narrative.9PubMed Central. Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults Studies in animal models confirm that LSD, along with other serotonergic psychedelics, causes a global decrease in synchronized EEG activity across virtually the entire measurable frequency range.10Translational Psychiatry. Psilocin, LSD, mescaline, and DOB all induce broadband desynchronization of EEG and disconnection in rats with robust translational validity
This desynchronization might sound like brain activity is decreasing, but what is actually happening is more like the brain’s normal filtering system getting overwhelmed. Electrophysiology work in mice found that LSD decreases activity in the reticular thalamus, a structure that normally acts as a gatekeeper controlling what sensory information reaches the cortex. With this gate weakened, more raw sensory data floods through. At the same time, LSD disrupts the associative networks that would normally integrate all that information into a coherent narrative. The net result is more information coming in but less ability to organize it.11PubMed Central. Lysergic acid diethylamide differentially modulates the reticular thalamus, mediodorsal thalamus, and infralimbic prefrontal cortex This goes a long way toward explaining why an LSD trip feels simultaneously overwhelming and revelatory.
Neuroimaging studies also show that LSD decreases connectivity within the default mode network while increasing connections between brain networks that do not normally talk to each other.8PubMed Central. Default Mode Network Modulation by Psychedelics: A Systematic Review This cross-talk between normally siloed networks is thought to underlie the synesthesia, novel associations, and sense of interconnectedness that characterize the psychedelic state.
Why the Effects Last So Long
One of LSD’s most distinctive features is its duration. A typical trip lasts eight to twelve hours, far longer than most other serotonergic psychedelics. Psilocybin trips last four to six hours; DMT, when smoked, lasts minutes. The explanation turns out to be structural. When researchers solved the crystal structure of LSD bound to a serotonin receptor, they discovered that a section of the receptor’s extracellular loop folds over the drug molecule like a lid, physically trapping it inside the binding pocket.12PubMed Central. Crystal Structure of an LSD-Bound Human Serotonin Receptor
Molecular dynamics simulations showed that this lid, held in place by a specific amino acid acting as a latch, rarely shifts enough to let the drug escape. When researchers mutated that amino acid to loosen the latch, LSD’s residence time dropped roughly tenfold, from about 44 minutes to just over 4 minutes.13Cell. Crystal Structure of an LSD-Bound Human Serotonin Receptor This mechanical trapping explains why such a tiny amount of drug, measured in millionths of a gram, can produce effects lasting most of a day. It is not that LSD is unusually potent at the receptor in a biochemical sense; it just refuses to leave.
What Microdoses Do and Do Not Do
The microdosing trend, where people take roughly a tenth of a standard dose every few days, highlights the stimulant-like face of LSD. In a placebo-controlled study, a low dose of LSD significantly increased self-reported vigor compared to placebo on standardized mood questionnaires.14PubMed Central. Acute subjective and behavioral effects of microdoses of LSD in healthy human volunteers Early exploratory research and survey data suggest that microdosers commonly report improvements in mood, focus, and creativity.15PubMed. The Viability of Microdosing Psychedelics as a Strategy to Enhance Cognition and Well-being – An Early Review
These self-reports sound like stimulant benefits, and that is precisely why people reach for stimulant language when describing LSD. But the controlled evidence is still thin, and expectancy effects (feeling energized partly because you believe you took something energizing) are notoriously hard to separate from pharmacological effects at sub-perceptual doses. What the microdosing data does demonstrate is that at very low levels, LSD’s stimulant-like qualities can show up even without the full hallucinogenic experience. The drug’s pharmacology doesn’t flip from “hallucinogen” to “stimulant” at lower doses; the stimulant-like component is always there, it just becomes more noticeable when the perceptual fireworks are turned way down.
Tolerance Builds Fast, But Withdrawal Does Not
LSD’s tolerance profile is another way it differs from both classical stimulants and depressants. Tolerance to LSD’s psychological and somatic effects develops rapidly, sometimes within just a few days of repeated use. The pupil dilation (mydriasis) that accompanies an LSD trip is the most reliably tolerance-prone physical effect. Crucially, about five days of abstinence is enough for tolerance to reverse completely, and withdrawal symptoms are not encountered.16Academic Press. Tolerance to Lysergic Acid Diethylamide: Overview, Correlates, and Clinical Implications
This is a meaningful practical distinction. Stimulants like amphetamines and cocaine produce tolerance but also carry clear dependence and withdrawal syndromes, including fatigue, depression, and intense cravings. Depressants like alcohol and benzodiazepines can produce physically dangerous withdrawal, including seizures. LSD does neither. You can build tolerance quickly, but when you stop, there is no rebound or withdrawal syndrome. This lack of dependence liability is one of the pharmacological features that sets psychedelics apart as a drug class and is partly why researchers have been willing to revisit them as therapeutic tools.
How LSD Compares to Amphetamine in a Direct Test
The clearest picture of where LSD sits relative to a “real” stimulant comes from a study that directly compared LSD, MDMA, and d-amphetamine in the same subjects under controlled conditions. LSD produced greater overall drug effects, greater subjective “stimulation,” and greater “drug high” ratings than d-amphetamine.3PubMed Central. Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects At first glance, that might seem to support calling LSD a stimulant. But LSD also produced far more “bad drug effect” and “ego dissolution” than amphetamine, effects that have nothing to do with stimulation and everything to do with the hallucinogenic core of the experience.
The researchers framed the distinction clearly: psychostimulants primarily activate dopamine and norepinephrine systems with minimal serotonin involvement, while LSD is fundamentally a serotonergic hallucinogen that happens to also engage dopamine pathways. The stimulation you feel on LSD is real, measurable, and pharmacologically grounded, but it rides on top of a hallucinogenic experience rather than defining it. On amphetamine, you feel awake and driven. On LSD, you feel awake, driven, and also like reality has been taken apart and reassembled in an unfamiliar order.
Hyperthermia and Body Temperature
One physical effect that sits at the intersection of stimulant-like sympathetic activation and hallucinogen pharmacology is hyperthermia, the elevation of body temperature. LSD reliably raises body temperature in both humans and animals. Animal research showed that LSD-induced hyperthermia could be blocked either by pretreating with neurotransmitter receptor antagonists or simply by placing the animal in a cold environment afterward, suggesting the temperature rise depends on active receptor signaling rather than being a nonspecific toxic effect.17PubMed. Disaggregation of brain polysomes after LSD in vivo. Involvement of LSD-induced hyperthermia This receptor-mediated hyperthermia is a feature shared with stimulants like MDMA and methamphetamine, both of which can dangerously elevate body temperature in hot environments or during physical exertion.
At standard recreational doses, LSD’s temperature increase is modest and not typically dangerous. But in massive overdose situations, hyperthermia becomes one of the most medically concerning effects. A case report describing eight patients who accidentally snorted large quantities of pure LSD powder documented hyperthermia, coma, respiratory arrest, and signs of sympathetic overactivity. All eight survived with supportive care, but the episode demonstrated that LSD can push the body’s stress response to life-threatening extremes when the dose is wildly excessive.18PubMed Central. Coma, hyperthermia and bleeding associated with massive LSD overdose. A report of eight cases
When Drug Categories Break Down
The stimulant-depressant-hallucinogen framework is a simplification that predates modern pharmacology. It was useful in an era when drug policy and education needed broad buckets for public communication, but it was never designed to capture drugs with complex receptor profiles. LSD acts on at least two major neurotransmitter systems (serotonin and dopamine), binds to numerous receptor subtypes, and produces effects that span perceptual, cognitive, emotional, and autonomic domains simultaneously. Forcing it into one category means ignoring real pharmacology.
Other drugs strain the same framework. Ketamine is classified as a dissociative anesthetic but has antidepressant effects. Cannabis is sometimes listed as a hallucinogen, sometimes as a depressant, sometimes as both. MDMA is often called an “empathogen” precisely because calling it a stimulant or hallucinogen alone misses too much. LSD is the original case study in why a three-bucket system fails. If you need a single label, “hallucinogen” is correct. If you want the whole picture, LSD is a serotonergic psychedelic with meaningful dopaminergic and sympathomimetic activity, a drug that rewires perception while simultaneously revving up the body. The categories are a starting point for understanding it, not the final word.